Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    Rules & Regulations

      Companies to Need License for Bio-prospecting.

      Small Firms Seek More Time to Implement GMP.

      Japan Calls for Sustainable Sea Resources.

      New Law to Acquire More Kidneys for Transplant.

      Feed Producers Want Long-term Policies.

    • articleNo Access

      General Information & Statistics

        Mental Health Survey of Junior Medical Officers.

        Gene Silencing Tools Released by CSIRO.

        China Participated in Global Sleeping Disorder Survey.

        Beijing Opens Liver Cancer Prevention Center.

        Hong Kong Bird Flu Virus Strikes Again.

        Emergency BP Drug Could be Potentially Fatal.

        Vitamin Prices Spirals in India Amidst Fears of Supply Cuts.

        India's Healthcare Industry Likely to Get Tax Concessions.

        Egg Bank Opens in Japan.

        AstraZeneca Under Investigation for Research Suppression on Lung Cancer Drug Irresa.

        Paper Review for Genetically Modified Crops.

        Harmful Corticosteroid Dosage in Asthma Inhalers.

      • articleNo Access

        Company News

          Panvax’s Foot-and-Mouth Vaccine Program.

          Agenix’s ThromboView Phase Ia Blood Clot Trial Successful.

          Sino-Australian Joint Venture Established.

          Beijing Deweizhi’s Latest Drug Procurement Agreement.

          Shandong Enterprises Collaborate with Beijing Universities.

          Shandong Qilu Pharmaceutical Launches Indobufen Tablets.

          Domestic AIDS Drug Cleared For Marketing.

          Azithromycin Powder Marketed by Zhejiang Kangyu.

          Trial Reforms in Zhejiang Drug Distribution Industry.

          Anti-Cancer Drug Enters Phase II Clinical Trials.

          Bioway’s Nerve Growth Factor Put into Production.

          Latest Drug Delivery Center in Operation.

          Metahelix Signs Genome Research Deal with ViaLactia Biosciences.

          AstraZeneca Seeks Exclusive Marketing Rights for New Drugs in India.

          Imaging Technology Utilized in Meat Contaminant Screening.

          Inproser Launches In’novase Project in Malaysia.

          Asia’s First Human Insulin Plant.

          World’s Smallest Heart Pump Undergoing Clinical Trial.

          Kaohxiong Biological Product Co. Signs Distribution Agreement with Bayer.

          Agilent Technologies Expands Mass Spectrometry Portfolio with New MS Instruments and Proteomics Software.

        • articleNo Access

          Industry Watch

            Agenix Limited Annual Results.

            Axon's Strategy Does the Trick.

            Pro Medicus Records Strong Profit Performances.

            AstraZeneca Launches Nexium in China.

            Beijing Shuanglu Pharma Markets Recombinant Human Interleukin-II.

            Shanghai Squibb Launches Tequin.

            Shanghai Wanxing Biopharma to Conduct Clinical Trials on Malaria Vaccine.

            Cipla Registers Anti-AIDS Drugs in South Africa.

            NDDB Commercializes Rabies Vaccine.

            ITRI and HP Collaborate in System Biology Bioinformatics Project.

            GlaxoSmithKline Plans to Establish R&D Facility in Taiwan.

          • articleNo Access

            General News

              New Biotech Research Lab to Open in Malaysia.

              AstraZeneca Considers Move to Asia.

              Scientists Discover how the Ebola Virus Infects Cells.

            • articleNo Access

              BioBoard

                Beijing Builds Asia's Largest Biotech Incubator.

                AstraZeneca to Build a Cancer Research Center in China.

                Agricultural Biotechnology International Conference in Melbourne.

                NTU and Mayo Collaborate on Cancer Cure.

                Bird Flu Deaths in Jakarta.

                Singapore and India Partner to Study Oral and Throat Cancers.

                Drug Scandal in China.

                St. Jude Children's Research Hospital, Singapore's National University Hospital and Viva Foundation to Help Children with Cancer.

                Novo Nordisk to Set up New Global Patent Unit in India.

                Vaccine Researcher Critical of CSL and Australian Government's Approach to Bird Flu.

              • articleNo Access

                BioBoard

                  Ian Frazer Named Australian of the Year.

                  Further Funding For Australian Medical Research.

                  Blockbuster Gardisil Approved by FDA.

                  Potential Ovarian Cancer Diagnostic Test on Trial in Melbourne.

                  Seven Scientists Elected as CAS Foreign Members.

                  CAS and University of Tokyo Set up Joint Laboratories.

                  AstraZeneca to Invest $100 million in China.

                  Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS) Partner with the Danish Pharmaceutical Company Lundbeck.

                  Anti-flu Tamiflu Approved in China.

                  China Develops New Bird Flu Vaccines.

                  China Collaborates with WHO to Fight Infectious Diseases.

                  Apollo Hospitals Eyes Acquisition in South-East Asia.

                  India Opens New Free AIDS Therapy Centers.

                  Ranbaxy Faces Criminal Charges for Price-fixing of Antibiotics and Warfarin.

                  Nobel Laureate Norman E. Borlaug Calls for Gene Revolution in India.

                  Carlyle Asia Growth Partners III Raises US$668 Million to Support Emerging Asian Business Leaders with Expansion Capital.

                  Kyoto University and Summit Pharmaceuticals International Corp Collaborate.

                  Grain Crisis Looms in Japan.

                  University Student Named New Zealand's Young Scientist of the Year.

                  New Boost in New Zealand Biotech Industry.

                  HP and A*STAR to Open $30 Million R&D Lab.

                  A*STAR to Collaborate with Australian National University.

                  Singapore's BAC Announces Biomedical Research Data to be Off-limits to Third Parties.

                • articleNo Access

                  BIOBOARD

                    INDIA — Asianhhm.com introduces innovative print and digital advertising solutions.

                    INDONESIA — IMCD acquires leading Indonesian food ingredients distributor Alam Subur.

                    JAPAN — VITAL Corporation to distribute Imagine Eyes' rtx1™ Adaptive Optics Retinal Camera in Japan.

                    SINGAPORE — Global threat of multi-drug-resistant Tuberculosis.

                    SINGAPORE — APAC breeding ground for Anti-bacterial household product innovation.

                    AUSTRALIA — In defence of the humble ant, champion of biodiversity.

                    AUSTRALIA — Senz Oncology initiates VAL-1000 clinical trial in patients with acute leukemias.

                    AUSTRALIA — ABRAXANE® demonstrates significant improvement in advanced melanoma patients.

                    AUSTRALIA — Alzheimer's, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration.

                    AUSTRALIA — Nine Sydney researchers to receive funding for biomedical research projects.

                    AMERICAS — How blind mole rats keep cancer at bay.

                    AMERICAS — No assembly required for new micro particles.

                    AMERICAS — Caribbean sardine collapse linked to climate change.

                    EUROPE — Radioembolization using sir-spheres significantly improves overall survival for patients with inoperable colorectal cancer.

                  • articleNo Access

                    EYE ON CHINA

                      Singapore-Based AAMG To Lead Project Management to Establish Zhuhai-Singapore Life Science Park which will offer World-Class Health & Medical Services in Southern China

                      Boston Therapeutics’ Hong Kong Affiliate Advance Pharmaceutical’s BTI-320 Clinical Trial Reaches Mid-Point by Enrolling 30 Patients at the Chinese University of Hong Kong

                      China Green Agriculture’s Online Sales Platform Begins Operations

                      Mixed-species Flocks Important for Biodiversity Conservation in Tropics

                      LICP Designs Hydrogels with Extraordinary Mechanical Properties and Good Self-recovery

                      AstraZeneca and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Designed to Support Linaclotide Approval in China

                      GE to Build Wind Education Centre in China

                      Chinese Scientists Edit Genes to Produce Artificial Sperm Capable of Creating “army of half-cloned mice”

                      Brain ‘switch’ can Turn off Drug Addiction, Say Shanghai Scientists

                      Mindray Medical Completes Acquisition of Wuhan Dragonbio

                      China Nepstar Chain Drugstore Ltd. Announces Formation of Special Committee to Consider “Going Private” Proposal

                      BioNano Genomics Announces Addition of Gene Company as China Mainland and HK/Macau Distributor

                      Novel Imaging Technology REFI takes Clinicians closer to detecting Stage 0 Tumour Lesions

                    • articleNo Access

                      INSIDE INDUSTRY

                        XELJANZ™ (Tofacitinib Citrate), A new class of treatment for Rheumatoid Arthritis Approved in Singapore

                        A new statement from World-Class Position in Eye Care: Allergen Successfully completes Oculeve Acquisition

                        VIASPACE Giant King® Grass Converted to Polymeric Carbon Solid Biofuel as Drop-In Replacement for Coal

                        ContourGlobal and the Republic of Armenia Announce Purchase of the Vorotan Hydroelectric Facility – IFC of the World Bank Group to Invest alongside CountourGlobal

                        Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain Antitrust Approval in Brazil for Planned Acquisition

                        Omidria® Approved for Commercialization throughout the European Union and Additional Countries

                        iBio to Receive US patent for Influenza Therapeutic

                        AstraZeneca broadens the Shoulders and to pay Inovio up to $700 Million for Cancer Drug

                        Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology

                      • articleNo Access

                        EYE ON CHINA

                          New births in China reached 18.5 million in 2016.

                          2017 Future Science Prize winners announced: Yigong Shi, Jianwei Pan, Chenyang Xu.

                          Smart nano-pesticide to combat soil and water contamination.

                          Nanotech applications lag behind research output.

                          China plans to launch “brain project” by year end.

                          AliHealth builds up online pharmacy in China.

                          Internet of Things for better health solutions.

                          Knowledge sharing via the Digital Silk Road.

                          UNAIDS encourages Chinese to produce drugs for Africa.

                        • articleNo Access

                          EYE ON CHINA

                            Chinese Academy of Sciences sets up innovation center in Bangkok

                            Chinese researchers map key protein in DNA repair with nearatomic resolution

                            Scientists close in on origin of SARS

                            AstraZeneca to develop new drugs with Chinese partner

                            European medical training facility opens China office

                            China’s biotech industry output to exceed 1.21 trillion dollars by 2020

                            Chinese-made ventricular assist device enters clinical testing

                            Novogen to establish China entity to further commercialization and partnerships in China

                            Eisai’s Aricept approved for additional indication of severe Alzheimer’s disease in China

                          • articleNo Access

                            Inside Industry

                              The following topics are under this section:

                              • AUM Biosciences obtains global rights to novel targeted cancer therapy
                              • Vitafoods Asia Conference to present top 5 APAC nutraceutical trends
                              • Weight Loss Made Simple – MyDoc Launches Medically supervised LivingLite™, in Singapore and the region
                              • Taiwan boosts development of biomedical industry through memorandums promoting a next-generation biomedical research ecosystem
                              • Mount Alvernia Hospital appoints ICON SOC to build new state-of-theart integrated cancer centre
                              • Healthy Hearts, Healthy Aging Asia Pacific report calls for specific policy actions and focus in managing cardiovascular disease
                              • Anticancer agent Halaven approved for treatment of locally advanced or metastatic breast cancer in China
                              • Advent Access receives CE Mark certificate for pioneering av-Guardian™ vascular access system
                              • ACT Genomics opens third laboratory in Asia at Hong Kong Science Park
                              • GSK opens new state-of-the-art pharmaceutical manufacturing facility in Singapore
                              • Taiwan Protein Project successfully enhances Taiwan' biotechnology R&D industry
                              • S$6.4 million boost for NUHS to push Artificial Intelligence (AI) in Healthcare Efficiency and Outcome
                              • HKUST Researchers Co-Discover a Novel Function of an Enzyme Offering Insight into the Pathology of Hereditary Spastic Paraplegia

                            • articleNo Access

                              OPEN INNOVATION GROUNDWORK

                              Although the concept of open innovation has gained much attention in the field of innovation management, few studies have so far theorized how such initiatives are being enacted in practice. This study is based on an inductive empirical analysis of how AstraZeneca, a large biopharmaceutical corporation, implemented an open innovation initiative called BioVentureHub. In the paper we introduce a theoretical model of open innovation enactment based on four interrelated processes. Three of these processes — conceptualization, mobilization, and operationalization — include activities related to preparing for open innovation, what we call open innovation groundwork. The fourth process — facilitation — involves translating the groundwork into actual open innovation.

                              The study contributes to the broader open innovation domain by its detailed account and theorizing of how open innovation is established in practice. Our methodological approach complements the previous research on open innovation that mostly are based on retrospective accounts or are conceptual in nature. Moreover, the study contributes by illustrating a novel initiative from the life science industry, where open innovation is frequently discussed but where still only a few empirical examples are found in academic literature